Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04928872 · ClinicalTrials.gov registry record
Macronutrient Distribution and Plasma Metabolites to Model Meals Composition
A clinical trial, sponsored by Texas A&M University.
- Completed
- Registry status
- 23
- Enrollment target
NCT04928872 is a clinical trial that has completed, run by Texas A&M University. The registered enrollment target is 23 participants.
The verdict
NCT04928872 has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Continuous glucose monitors (CGMs) measure plasma glucose concentration continually and thus they are a key tool in the management of diabetes, including type 2 diabetes (T2D). A key factor in diabetes management is a reduction of dietary carbohydrates (CHO) and/or exchanging high glycemic index (GI) CHO with low GI CHO. However, the protein and fat content of the meal can have a significant impact on the glucose readings obtained from a CGM as there is no enough data available on their sensitivity during meals.
Interventions
- COMBINATION_PRODUCT Predefined meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2020-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04928872
The ClinicalTrials.gov registry entry for NCT04928872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Predefined meal is the first listed.
NCT04928872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04928872 about?
NCT04928872 is a clinical study titled "Macronutrient Distribution and Plasma Metabolites to Model Meals Composition". Continuous glucose monitors (CGMs) measure plasma glucose concentration continually and thus they are a key tool in the management of diabetes, including type 2 diabetes (T2D). A key factor in diabetes management is a reduction of dietary carbohydrates (CHO) and/or exchanging high glycemic index (GI...
What is the current status of trial NCT04928872?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2018-06-20. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT04928872?
The interventions under investigation include: Predefined meal (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04928872?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.